Caixin App
Newsletter
Weekly Magazine
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Commentary & Analysis
Weekend Long Read
Video
ESG
Topics
China Goes Global
Asia New Vision Forum 2025
Asia New Vision Forum 2024
Selected
CX Daily
Weekly Must-Read
Caixin Briefs
Economic Indexes
Caixin Explains
News Graphics
ThinkChina
The Wall Street Journal
Podcast
Highlights
Newsletter
Events
Impact
Asia Central Banking
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
"Fosun"
Chinese AI Startups Extend Post-Listing Rally in Hong Kong
, which remain scarce in China’s equity market. An investment executive at
Fosun
Asset Management Ltd
In Depth: The Battle to Make Cancer’s ‘Living Drug’ Affordable
of expectations.
Fosun
Kite Biotechnology Co. Ltd.’s Yescarta (Yikaida), the first CAR-T approved
Exclusive: Beijing Drafts Rules to Link Private Insurance With Pricey Innovative Medicines
implementation was highlighted by a recent reversal at
Fosun
United Health Insurance. On Dec. 16
China Opens New Insurance Path for High-Cost Drugs
talks for the commercial list.
Fosun
Kite’s axicabtagene ciloleucel and JW Therapeutics
In Depth: China’s Pharma Pioneers in Africa Dig In for the Long Haul
. ( 600079.SH ) and Shanghai
Fosun
Pharmaceutical Group Co. Ltd. ( 600196.SH ) have established
In Depth: Lawsuits Lay Bare Shortcomings of China’s Commercial Insurers
Mengda bought a children’s critical illness policy for her four-month-old son, Haohao, from
Fosun
United
In Depth: New Innovative Drug List Could Expand Access to Costly Breakthroughs
Ltd., IASO Bio and CARsgen Therapeutics Ltd. Others, including Shanghai
Fosun
Kairos Biotechnology
Hong Kong Regulators Issue Warning to Cool Stablecoin Frenzy
. 12, when Tencent News reported that
Fosun
International Chairman Guo Guangchang led a delegation
Exclusive: HNA Co-Founder Jailed as Curtain Falls on Debt-Fueled Empire
Insurance Group ,
Fosun
Group, and Dalian Wanda Group. In December 2017, China’s top economic planning
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 21.3% in 2024
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) ( 600196.SH ) reported a net
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通